← Insider buys
FATE

Fate Therapeutics, Inc. · Healthcare

Chief R, D Officer Bahram Valamehr sold $1.2M of Fate Therapeutics, Inc.

Sold$1,191,406
$47.66Price
25,000Shares
−14%Stake

What FATE did after the filing

Prices for FATE after this filing aren't in yet.

Traded Mon, Dec 13. Filed Tue, Dec 14, 11:18 AM ET, during the session. Not investment advice.